Arora products have been used in more than four million procedures at 600 hospitals.
Aroa says that Endoform is 20 per cent to 60 per cent less expensive than competing biological regeneration products, while only slightly more expensive than synthetic scaffolding technology..
In FY2020 the company had product revenue of $NZ22 million ($A20.6 million) and was earnings positive.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
62.5¢ |
Change
0.015(2.46%) |
Mkt cap ! $215.6M | |||
| Open | High | Low | Value | Volume |
| 61.0¢ | 63.0¢ | 61.0¢ | $314.7K | 504.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10700 | 60.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 63.0¢ | 191221 | 5 |
View Market Depth
| Last trade - 16.10pm 12/08/2025 (20 minute delay) ? |
| ARX (ASX) Chart |